IPHA vs DOUG
Comparison between Innate Pharma (IPHA, Company) and Douglas Elliman Inc (DOUG, Company).
IPHA is from the Healthcare sector, while DOUG is from the Real Estate sector.
5-Year PerformanceIPHA has outperformed DOUG, delivering a return of -11.8% compared to -32.5%
IPHA vs DOUG - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
IPHA vs DOUG - Historical Returns
Returns include dividend reinvestment.
IPHA vs DOUG - Annual Returns (2019 - 2026)
Returns include dividend reinvestment.
| Year | IPHA | DOUG |
|---|---|---|
| 2026 | -2.75% | -23.25% |
| 2025 | -6.42% | +45.40% |
| 2024 | -32.35% | -42.61% |
| 2023 | -17.65% | -23.85% |
| 2022 | -22.29% | -61.06% |
| 2021 | +5.80% | -5.19% |
| 2020 | -43.97% | N/A |
| 2019 | +6.45% | N/A |
IPHA vs DOUG Drawdown Comparison
The maximum drawdown for IPHA was -85.73%, occurring on Mar 20, 2026. This drawdown has not yet recovered.
The maximum drawdown for DOUG was -90.25%, occurring on Jun 17, 2024. This drawdown has not yet recovered.
The current IPHA drawdown is -78.41%. The current DOUG drawdown is -83.60%.
| Rank | IPHA | DOUG |
|---|---|---|
| #1 | -85.73% May 11, 2020 - Mar 20, 2026 | -90.25% Dec 30, 2021 - Jun 17, 2024 |
| #2 | -52.20% Feb 19, 2020 - May 11, 2020 | N/A |
| #3 | -12.06% Nov 11, 2019 - Jan 2, 2020 | N/A |
| #4 | -10.16% Jan 23, 2020 - Feb 13, 2020 | N/A |
| #5 | -9.99% Jan 8, 2020 - Jan 23, 2020 | N/A |
| #6 | -8.86% Oct 21, 2019 - Nov 5, 2019 | N/A |
| #7 | -4.27% Feb 13, 2020 - Feb 18, 2020 | N/A |
| #8 | -3.22% Nov 7, 2019 - Nov 11, 2019 | N/A |
| #9 | -1.78% Jan 2, 2020 - Jan 6, 2020 | N/A |
Correlation
Correlation between IPHA and DOUG is 0.71 which considered as a strong positive correlation - the stocks tend to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks